Cymarin
Based on 1 Customer Validation
Cymarin, a cardiac glycoside, potently inhibits the Palytoxin (PTX)-induced K+ release (IC50=0.42 μM). Cymarin reveals an antitumor activity against breast cancer and pancreatic cancer. Cymarin exhibits antifeedant and growth inhibitory effects as crop protectant.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 97.28%
- CAS 番号: 508-77-0
- 分子式: C30H44O9
- 分子量:548.66
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Parasite アイソフォーム固有の製品をすべて表示
More
生物活性
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Panel NCI-60 (60 carcinoma cell lines) | GI50 |
39 nM
Compound: Cymarin
|
Growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program
Growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program
|
[PMID: 15743190] |
Cymarin (0.25-1 μM) inhibites PAX6 expression by blocking IRES-directed translation and inhibits 47.8% proliferation of MCF-7 cells with the concentration of 1 μM [2].
Cymarin downregulates UGT1A10 expression, eliminates TRA-1-60 (IC50 of 15.2 nM) and TRA-1-81 cells (IC50 of 5.1 nM) in cell lines SW1990GR, inhibits proliferations and cell viabilities of pancreatic cancer cells SW1990 and SW1990GR (IC50 of 33.8 nM for SW1990 and 40.8 nM for SW1990GR)[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SW1990 and SW1990GR
-
Concentration:0-500 nM
-
Incubation Time:72 h
-
Result:Decreased cell viability with IC50 of 33.8 nM for SW1990 and 40.8 for SW1990GR.
-
Cell Line:MCF-7
-
Concentration:0.25-1 μM
-
Incubation Time:5 days
-
Result:Inhibits proliferation of MCF-7 cells in a dose-dependent manner.
-
Cell Line:MCF-7
-
Concentration:0.25-1 μM
-
Incubation Time:24 h
-
Result:Downregulated levels of PAX6.
-
Cell Line:SW1990 and SW1990GR
-
Concentration:7-15 μM
-
Incubation Time:
-
Result:Decreased levels of UGT1A10 transcription.
Cymarin (2 mg/kg, i.p., twice a week for 3 weeks) inhibits tumor growth, eliminates TRA-1-60 cells and decreases chemoresistance in SW1990 xenografted nude mice[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Trichoplusia ni[3]
-
Dosage:1000 p.p.m.
-
Administration:p.o. for 10 days
-
Result:Inhibited growth and revealed a feeding deterrent to T.ni.
-
Animal Model:Luciferase labeled SW1990 xenograft in nude mice[4]
-
Dosage:2 mg/kg
-
Administration:i.p., twice a week for 3 weeks
-
Result:Inhibited tumor growth.
化学情報
-
CAS 番号 508-77-0
-
性状 Solid
-
分子量 548.66
-
分子式 C30H44O9
-
Color White to off-white
-
SMILES
O=C[C@@]12[C@]3([H])[C@](CC[C@@]1(C[C@@H](O[C@@]4([H])C[C@@H]([C@H](O)[C@@H](C)O4)OC)CC2)O)([H])[C@@]5([C@@](C)([C@@H](C(CO6)=CC6=O)CC5)CC3)O
-
Structure Classification
-
Initial Source
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
純度とドキュメンテーション
-
データシート (278 KB)
-
SDS (644 KB)
- English - EN (644 KB)
- Français - FR (644 KB)
- Deutsch - DE (644 KB)
- Norwegian - NO (644 KB)
- Español - ES (644 KB)
- Swedish - SV (644 KB)
- Italian - IT (644 KB)
- Korean - KR (644 KB)
- Portuguese - PT (644 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Ozaki H, et al. Interaction of palytoxin and cardiac glycosides on erythrocyte membrane and (Na+ + K+) ATPase. Eur J Biochem. 1985;152(2):475-480. [Content Brief]
[2]. Li Q, et al., Translation of paired box 6 (PAX6) mRNA is IRES-mediated and inhibited by cymarin in breast cancer cells. Genes Genet Syst. 2023 Oct 24;98(4):161-169. [Content Brief]
[4]. Tan L, et al., A targetable pathway to eliminate TRA-1-60+/TRA-1-81+ chemoresistant cancer cells. J Mol Cell Biol. 2023 Nov 27;15(6):mjad039. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)